| Detected | Trial | Change |
|---|---|---|
| 2026-07-17 | NCT06660667 A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-17 | NCT06660667 A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related… |
Trial sites expanded: 18 -> 26 locations |
| 2026-07-16 | NCT07185009 A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants… |
Trial sites expanded: 40 -> 46 locations |
| 2026-07-11 | NCT07094373 Validation of Chlamydia Diagnostic Codes in TriNetX US EHR Data |
date change Primary completion pushed: 2026-06-12 -> 2026-08-31 |
| 2026-07-11 | NCT07094373 Validation of Chlamydia Diagnostic Codes in TriNetX US EHR Data |
date change Completion pushed: 2026-06-12 -> 2026-08-31 |
| 2026-07-11 | NCT06716424 A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2… |
Trial completed |
| 2026-07-10 | NCT07615166 Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in… |
Trial completed |
| 2026-07-10 | NCT07615166 Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in… |
Enrollment increased: 124 -> 996 participants |
| 2026-07-08 | NCT07634692 An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During… |
Recruitment opened |
| 2026-07-03 | NCT06914908 Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic… |
Primary endpoint(s) modified |
| 2026-07-03 | NCT06914908 Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic… |
Enrollment increased: 64 -> 71 participants |
| 2026-07-02 | NCT07184931 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants… |
Trial sites expanded: 259 -> 301 locations |
| 2026-07-02 | NCT06676319 Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-02 | NCT06676319 Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma |
Enrollment reduced: 1147 -> 556 participants |
| 2026-07-02 | NCT06676319 Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma |
date change Primary completion moved earlier: 2027-09-17 -> 2027-06-21 |
| 2026-07-02 | NCT06676319 Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma |
date change Completion moved earlier: 2027-10-15 -> 2027-07-19 |
| 2026-07-02 | NCT06791291 Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes |
Primary endpoint(s) modified |
| 2026-07-02 | NCT07225569 A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With… |
Trial sites expanded: 63 -> 66 locations |
| 2026-07-02 | NCT07190196 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults… |
Trial sites expanded: 76 -> 79 locations |
| 2026-06-30 | NCT06111586 Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults… |
overall status: "Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-17 | NCT07710872 Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal… | Phase 3 | Not Yet Recruiting |
| 2026-07-15 | NCT07704580 Phase 1b/2 Study of IV Sarilumab in Adult With RA | Phase 1/2 | Recruiting |
| 2026-07-09 | NCT07692204 A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With… | Phase 2 | Not Yet Recruiting |
| 2026-07-07 | NCT07688213 A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With… | Phase 2 | Not Yet Recruiting |
| 2026-06-30 | NCT07675031 Managed Access Program of Venglustat in Pediatric and Adult Patients With Type 3 Gaucher… | Available |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06671587 | iGlarLixi CGM Study in Chinese T2D Individuals After OADs | Type 2 Diabetes (T2D) | Recruiting |
| NCT06666413 | China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With… | Glycogen Storage Disease Type II | Recruiting |
| NCT06145373 | A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe… | Hemophilia A | Recruiting |
| NCT07053423 | A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07286214 | Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica | Polymyalgia Rheumatica | Recruiting |
| NCT05757713 | Teplizumab in Pediatric Stage 2 Type 1 Diabetes | Diabetes Mellitus, Type 1 | Active, Not Recruiting |
| NCT07109297 | Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in… | RSV Immunization | Active, Not Recruiting |
| NCT05983068 | A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric… | Dermatitis Atopic | Active, Not Recruiting |
| NCT05097287 | Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline… | Asthma | Active, Not Recruiting |
| NCT07135973 | A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above… | Chronic Graft Versus Host Disease | Not Yet Recruiting |
| Phase 3 | |||
| NCT06293053 | A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6… | Prurigo Nodularis | Recruiting |
| NCT06191315 | Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic… | Wheezing | Recruiting |
| NCT07247188 | Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and… | Sickle Cell Disease | Recruiting |
| NCT07184996 | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants… | Ulcerative Colitis | Recruiting |
| NCT07103148 | A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population | Yellow Fever Immunization | Recruiting |
| NCT07348692 | Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy… | Pneumococcal Immunization | Recruiting |
| NCT07086976 | A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib… | Autoimmune Haemolytic Anaemia | Recruiting |
| NCT06290128 | A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory… | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Recruiting |
| NCT07190209 | Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07190222 | Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07007962 | Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune… | Immune Thrombocytopenia | Recruiting |
| NCT07184944 | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants… | Crohn's Disease | Recruiting |
| NCT06975865 | The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With… | Sickle Cell Disease | Recruiting |
| NCT07325292 | Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous… | Multiple Sclerosis | Recruiting |
| NCT07285460 | A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male… | Hemophilia | Recruiting |